Published on
02:53 GMT
Venclexta Treatment Combo is Being Reviewed by FDA For CLL
Treatment with the fixed-duration, all-oral combination regimen of Venclexta (venetoclax) and Calquence (acalabrutinib) was submitted to the U.S. Food and Drug Administration (FDA) for a supplemental new drug application by AbbVie, according to a news …
Source:
Cure Today
-
Neutral
